NO983295D0 - Kontroll av helingsprosess - Google Patents

Kontroll av helingsprosess

Info

Publication number
NO983295D0
NO983295D0 NO983295A NO983295A NO983295D0 NO 983295 D0 NO983295 D0 NO 983295D0 NO 983295 A NO983295 A NO 983295A NO 983295 A NO983295 A NO 983295A NO 983295 D0 NO983295 D0 NO 983295D0
Authority
NO
Norway
Prior art keywords
control
wound healing
healing process
healing processes
chitosans
Prior art date
Application number
NO983295A
Other languages
English (en)
Norwegian (no)
Other versions
NO983295L (no
Inventor
Hans-Arne Hansson
Original Assignee
Hansson Hans Arne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansson Hans Arne filed Critical Hansson Hans Arne
Publication of NO983295L publication Critical patent/NO983295L/no
Publication of NO983295D0 publication Critical patent/NO983295D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • General Induction Heating (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Moulding By Coating Moulds (AREA)
  • Controlling Rewinding, Feeding, Winding, Or Abnormalities Of Webs (AREA)
  • Control Of Metal Rolling (AREA)
NO983295A 1996-01-18 1998-07-16 Kontroll av helingsprosess NO983295D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600216A SE9600216D0 (sv) 1996-01-18 1996-01-18 Styrning av läkningsprocesser
PCT/SE1997/000057 WO1997025994A1 (en) 1996-01-18 1997-01-16 Control of healing process

Publications (2)

Publication Number Publication Date
NO983295L NO983295L (no) 1998-07-16
NO983295D0 true NO983295D0 (no) 1998-07-16

Family

ID=20401098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983295A NO983295D0 (no) 1996-01-18 1998-07-16 Kontroll av helingsprosess

Country Status (20)

Country Link
US (1) US6174855B1 (2)
EP (1) EP0874634B1 (2)
JP (2) JP4112006B2 (2)
KR (1) KR19990077331A (2)
CN (1) CN1213309A (2)
AT (1) ATE214280T1 (2)
AU (1) AU701260B2 (2)
BR (1) BR9707005A (2)
CA (1) CA2241983A1 (2)
CZ (1) CZ225098A3 (2)
DE (1) DE69711024T2 (2)
HU (1) HUP9902029A3 (2)
IL (1) IL125375A0 (2)
IS (1) IS4782A (2)
NO (1) NO983295D0 (2)
NZ (1) NZ326003A (2)
PL (1) PL327828A1 (2)
SE (1) SE9600216D0 (2)
TR (1) TR199801365T2 (2)
WO (1) WO1997025994A1 (2)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
JP4351041B2 (ja) * 2001-06-13 2009-10-28 ザ・ユニバーシティ・オブ・シドニー 傷治癒のための処置および組成物
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
CN1929849A (zh) * 2003-10-21 2007-03-14 株式会社奈特克 包括含糖链的脱乙酰壳多糖衍生物的内窥镜手术用粘膜膨胀液组合物
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US7450296B2 (en) 2006-01-30 2008-11-11 Taiwan Semiconductor Manufacturing Company, Ltd. Method and system for patterning alignment marks on a transparent substrate
EP2023874A4 (en) * 2006-06-02 2009-07-08 Bioseek Inc METHOD FOR IDENTIFYING ACTIVE SUBSTANCES AND THEIR USE FOR THE PREVENTION OF RESTENOSIS
EP2707485B1 (en) 2011-05-09 2016-12-14 The University Court of The University Of Glasgow Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen
EP3535390A4 (en) * 2016-11-02 2020-11-25 Inc. Aronora COMBINATION OF THROMBIN E-WE ANALOGUE AND FIBRINOLYTIC
CN106729676A (zh) * 2016-12-07 2017-05-31 杭州市萧山区中医院 水蛭素用于制备治疗术后肌腱粘连的药物中的应用
JP7264589B2 (ja) * 2017-12-25 2023-04-25 株式会社 資生堂 トロンビンの抑制作用を指標とした皮膚状態改善剤のスクリーニング方法、及びトロンビン作用阻害剤を含む皮膚状態改善剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JPS61253065A (ja) 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US5112608A (en) * 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
DK0426368T3 (da) * 1989-10-31 1995-03-13 Howmedica Præparater indeholdende chitinderivater til forebyggelse af adhæsion
US5209776A (en) 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
JPH04112006A (ja) * 1990-08-31 1992-04-14 Seiji Ichikawa セメント液作成方法
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives

Also Published As

Publication number Publication date
JP4112006B2 (ja) 2008-07-02
WO1997025994A1 (en) 1997-07-24
DE69711024T2 (de) 2002-09-19
IS4782A (is) 1998-06-24
HUP9902029A2 (hu) 1999-11-29
HUP9902029A3 (en) 2001-01-29
NZ326003A (en) 2001-03-30
ATE214280T1 (de) 2002-03-15
DE69711024D1 (de) 2002-04-18
EP0874634B1 (en) 2002-03-13
TR199801365T2 (xx) 1998-10-21
KR19990077331A (ko) 1999-10-25
JP2008163036A (ja) 2008-07-17
CZ225098A3 (cs) 1998-10-14
SE9600216D0 (sv) 1996-01-18
PL327828A1 (en) 1999-01-04
NO983295L (no) 1998-07-16
EP0874634A1 (en) 1998-11-04
IL125375A0 (en) 1999-03-12
JP2000503318A (ja) 2000-03-21
CA2241983A1 (en) 1997-07-24
AU701260B2 (en) 1999-01-21
CN1213309A (zh) 1999-04-07
BR9707005A (pt) 1999-07-20
US6174855B1 (en) 2001-01-16
AU1327197A (en) 1997-08-11

Similar Documents

Publication Publication Date Title
NO983295D0 (no) Kontroll av helingsprosess
IL131348A0 (en) Treatment and prevention of adhesions
IL135921A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
CA2220505A1 (en) N,o-carboxymethylchitosan for prevention of surgical adhesions
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
EP1776954A3 (en) The use of inhibitors of the renin-angiotensin system for the treatment of stroke
AU3717395A (en) Compositions for the treatment of skin disorders
DK0772446T3 (da) Anti-adhæsionsmiddel
ATE318141T1 (de) Verwendung von taurolidin oder taurultam zur herstellung eines arzneimittels zur vorbeugung von metastasen
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
WO1996040743A3 (en) Inhibitors of factor xa
EP0870502A3 (en) Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis
WO2002028433A3 (en) Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition
NO934653L (no) Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse
EP0330218A3 (en) Inhibitors of lysyl oxidase
NO20030841L (no) En ny spesifikk mekanisme for inhibering av blodplateadhesjon til kollagen
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
AU1569700A (en) Novel therapeutic application of low molecular weight heparin
WO2002005796A3 (en) Use of a spla2 inhibitor for the treatment of sepsis
DK0895478T3 (da) Bestanddel B som ardanner
RU98115584A (ru) Регулирование процесса заживления

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application